1. Home
  2. TECX vs ETD Comparison

TECX vs ETD Comparison

Compare TECX & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$34.54

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

HOLD

Current Price

$21.93

Market Cap

569.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
ETD
Founded
2019
1932
Country
United States
United States
Employees
60
N/A
Industry
Home Furnishings
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
569.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TECX
ETD
Price
$34.54
$21.93
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$75.20
$27.00
AVG Volume (30 Days)
182.5K
751.0K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
8.15%
EPS Growth
N/A
N/A
EPS
N/A
1.10
Revenue
N/A
$766,784,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.73
P/E Ratio
N/A
$19.75
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$18.28
52 Week High
$39.53
$31.41

Technical Indicators

Market Signals
Indicator
TECX
ETD
Relative Strength Index (RSI) 57.62 55.49
Support Level $27.31 $21.29
Resistance Level $35.99 $22.79
Average True Range (ATR) 2.47 0.67
MACD 0.25 -0.07
Stochastic Oscillator 50.14 48.03

Price Performance

Historical Comparison
TECX
ETD

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: